OpenClinica to Support Internationalization and Localization

Akaza Research expects to unveil a new version of OpenClinica that includes support for internationalization and localization.

Cambridge, Massachusetts (PRWEB) September 24, 2007 -- This October Akaza Research expects to unveil a new version of OpenClinica that includes support for internationalization and localization. These features will facilitate global clinical trials by allowing OpenClinica adopters to run the software in multiple languages and tailor the application to local cultures. The October release is version 2.2 of the popular open source clinical research software platform.

"The internationalization features in OpenClinica 2.2 will provide an easy-to-use general purpose infrastructure for running OpenClinica in any language," said Tom Hickerson OpenClinica's Senior Project Coordinator. "You can have a single instance of OpenClinica display Russian text to one user while displaying Japanese to another," he added.

OpenClinica 2.2 employs the Unicode standard, which allows a single server to support multiple languages and writing systems across multiple browsers and operating systems. In addition, OpenClinica 2.2 comes with an easy-to-use localization kit, allowing non-technical users to add translations for new languages. A complete Spanish translation of OpenClinica will be made publicly available along with the October release.

The localization kit was largely developed through OpenClinica's open source community by BAP Health Outcomes, a contract research organization based in Oviedo, Spain. BAP Health also contributed the Spanish language translation of OpenClinica 2.2. "We are pleased to have been able to collaborate on the international open source development of OpenClinica by providing this framework for translation. Further, we are proud to make OpenClinica the most accessible tool for clinical trial sites in 17 more countries by contributing the Spanish language translation," said Nacho M. Castejon, a Java developer at BAP who helped manage this effort.

About OpenClinica®

OpenClinica is open source web-based electronic data capture software for clinical research. It facilitates protocol configuration, design of case report forms, clinical data capture, and study/data management. OpenClinica supports HIPAA and 21 CFR Part 11 guidelines and is designed as a lightweight, standards-based, extensible, and modular platform. The current production release of OpenClinica is version 2.0.1. All versions of OpenClinica are available for download at www.OpenClinica.org.

About BAP Health Outcomes®

BAP Health Outcomes is a contract research organization that specializes in Health Outcomes Research. The company is based in Oviedo, Spain and offers a host of services in all areas of health outcomes research. BAP Health employs medical doctors, psychometric experts, economists, and software engineers. For more information see www.baphealth.com.

About Akaza Research®

Akaza Research, the leading provider of open source clinical trial software, is headquartered in Cambridge, Massachusetts. Supported by the National Institutes of Health (NIH), Akaza has developed and commercialized OpenClinica, the preeminent open source clinical trial data capture and management software platform. Akaza brings Open Source Software (OSS) into the mainstream of the clinical research enterprise by making robust, flexible, standards-based systems accessible for private and public research. Akaza Research provides OpenClinica support, training, and consulting services to its customers worldwide. See www.akazaresearch.com.

###

Suggested Articles

After delivering a "positive surprise" in December, Biogen is painting a fuller picture of its lupus drug.

A new CRISPR technique neutralizes SARS-CoV-2 by scrambling the virus' genetic code. It could prove useful for fighting other viruses, like influenza.

The deal, which follows a bidding war with AcelRx, gives Melinta another approved antibiotic and potentially complementary R&D expertise.